Revolution Medicines, Inc. (RVMD) insider trading

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Anthony Mancini

See Remarks

—

$431.95K (1) scheduled

−$431.95K

39,765

0.0186%

$7.44M

−27.2%

Alexis Borisy

Director

—

2,340,075

1.09%

$437.57M

+0.2%

Thilo Schroeder

Director

—

760,869

0.3550%

$142.27M

—

Mark A Goldsmith

See Remarks

—

376,190

0.1755%

$70.34M

+50.2%

Stephen Michael Kelsey

See Remarks

—

286,307

0.1336%

$53.54M

+7.8%

Margaret A Horn

Chief Operating Officer

—

149,680

0.0698%

$27.99M

+12.0%

Jack Anders

Chief Financial Officer

—

119,216

0.0556%

$22.29M

+18.9%

Xiaolin Wang

See Remarks

—

116,063

0.0541%

$21.70M

+33.9%

Lin Wei

Chief Medical Officer

—

101,366

0.0473%

$18.95M

−10.7%

Sandra Horning

Director

—

97,765

0.0456%

$18.28M

+4.6%

Alan B. Sandler

Chief Development Officer

—

52,559

0.0245%

$9.83M

−1.2%

Jeff Cislini

SVP & General Counsel

—

51,776

0.0242%

$9.68M

+12.0%

Elizabeth M Anderson

Director

—

34,333

0.0160%

$6.42M

−2.1%

Flavia Borellini

Director

—

26,215

0.0122%

$4.90M

+19.8%

Sushil Patel

Director

—

21,656

0.0101%

$4.05M

+8.6%

Frank Clyburn

Director

—

10,929

0.0051%

$2.04M

+57.7%

Lorence H. Kim

Director

—

1,191

0.0006%

$222.71K

−98.3%

Revolution Medicines, Inc.

What the insiders did Scheduled selling only

By person